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Abstract
Objective: To evaluate the frequency of the real association between paracoccidioidomycosis (PCM) and tuberculosis (TB) as well as the 
rate of previous TB misdiagnosis in individuals with PCM among the patients treated in the Pulmonology Division of the State University 
of Campinas Hospital das Clínicas, Campinas, Brazil. Methods: A retrospective study of 227 adult patients with PCM (chronic form) treated 
between 1980 and 2005. Results: Of the 227 patients studied, 36 (15.8%) had been previously treated for TB. However, only 18 (7.9%) 
presented positive sputum smear microscopy results. The remaining 18 (7.9%) neither presented positive sputum smear microscopy nor 
showed improvement after receiving specific anti-TB treatment. Conclusion: Although the existence of an association between PCM and TB 
has been documented in the literature, misdiagnosis is common due to the superimposition of and the similarity between their clinical and 
radiographic presentations, thereby warranting the need for bacteriological diagnosis before initiating specific treatment.
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Introduction
The combination of paracoccidioidomycosis 
(PCM) and tuberculosis (TB) has long been recognized 
by clinicians. The diseases can occur simultaneously 
or sequentially. Data in the literature indicate that 
the frequency of this combination ranges from 5.5 
to 19%.(1,2) A drop in cellular immunity seems to be 
the principal trigger for both diseases.(3,4) Deficient 
production of certain cytokines, such as interleukin 
(IL)-12, IL-23, and interferon gamma (IFN-γ), as 
well as of their receptors, predisposes patients to TB 
and to PCM.(5) 
Since the clinical presentation of these diseases 
can be similar, it has been observed that several 
patients definitively diagnosed with PCM had been 
previously treated for TB, although without sputum 
smear microscopy confirmation. Most of those 
patients did not respond to specific anti-TB treat-
ment and only improved after drug treatment for 
PCM had been started. 
Misdiagnosis is rare in patients treated at tertiary 
care teaching hospitals, being more common in 
patients initially treated at basic health clinics and 
in whom the clinical/radiological presentation does 
not allow a clear distinction to be made between 
the two diseases. 
The objective of the present study was to eval-
uate the true frequency of the combination of the 
two diseases as well as the rate at which PCM has 
previously been misdiagnosed as TB.
Methods
A retrospective study was conducted through a 
review of the medical charts of the patients with 
PCM treated in the Pulmonology Outpatient Clinic 
of the Clinical Medicine Department of the State 
University of Campinas School of Medical Sciences 
Hospital das Clínicas between 1980 and 2005. 
We included 227 adult patients diagnosed with 
the chronic form of PCM, in whom the fungus 
Paracoccidioides brasiliensis had been identified 
directly in the sputum culture or indirectly in the 
Grocott staining of the bronchial lavage fluid.
The variables analyzed were as follows: age, 
gender, clinical complaints, chest radiological 
alterations, and diagnostic confirmation of TB. 
The results of direct testing and sputum culture 
for Koch’s bacillus were obtained from the patient 
medical chart or from results obtained in the public 
health facilities of origin where the previous treat-
ment for TB had been performed. 
Results
Of the 227 patients with PCM, 215 (95%) were 
male, and only 12 (5%) were female. In all of the 
patients, the diagnosis of PCM was confirmed 
through the identification of P. brasiliensis in the 
sputum or in the bronchial lavage fluid. All were 
being treated or had already been treated with 
itraconazole, amphotericin B, or the trimethoprim-
sulfamethoxazole combination.
Of the 227 patients, 36 (15.8%) reported 
having been previously treated for TB. However, 
only 18 (7.9%) presented positive sputum smear 
microscopy for acid-fast bacilli or positive sputum 
culture for Mycobacterium tuberculosis. Of those 
18 patients, 17 were Caucasian males, presenting 
a mean age at the time of diagnosis of 43.3 years 
(range, 30-56 years). The remaining 18 patients, all 
of whom were Caucasian males, presented a mean 
age at the time of diagnosis of 49 years (range, 
35-69 years), presented negative results, and did not 
present clinical improvement after the anti-TB treat-
ment had been started. However, all 18 responded 
to the anti-PCM treatment (Figure 1).
Of the 36 patients with a history of previous 
treatment for TB, 28 (77.7%) had been diagnosed 
with TB (or had been suspected of having TB) prior 
227 patients with PCM
36 (15.8%) previously treated for TB
18 (7.9%) with positivity for AFB (testing or culture)
18 (7.9%) with negativity for AFB and no clinical improvement after anti-TB treatment
Figure 1 - Flowchart of the patients studied. PCM: paracoccidioidomycosis; TB: tuberculosis; AFB: acid-fast bacilli.
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to being diagnosed with PCM, 4 (11.1%) had been 
diagnosed with PCM prior to being diagnosed with 
TB, and 4 (11.1%) had been diagnosed with both 
diseases simultaneously.
In most cases, the clinical complaints, the physical 
examination data, and the radiological alterations 
presented by these patients did not allow a clear 
distinction to be made between the two diseases in 
most cases (Figures 2-4).
One case in particular seems to be illustrative 
of a true combination of PCM and TB. Eight years 
ago, the patient was definitively diagnosed with 
PCM through positive sputum smear testing for 
P. brasiliensis and was treated with trimethoprim-
sulfamethoxazole for two years. The treatment was 
then suspended due to clinical improvement and 
negative serology. This patient again presented 
respiratory complaints five years after the end of 
the anti-PCM treatment, at which point he was 
diagnosed with TB (through positive sputum smear 
microscopy for acid-fast bacilli) and treated with 
Regimen I (rifampicin, isoniazid, and pyrazinamide). 
There was a good clinical response, and the patient 
was considered cured. Four months after the end of 
the anti-TB treatment, the patient again complained 
of fever, weight loss, mild productive cough, 
and dyspnea, Recurrence of PCM was confirmed 
(Figure 5), and the treatment with trimethoprim-
sulfamethoxazole was restarted. 
Figure 2 - Chest X-ray showing bilateral lung opacities 
predominantly in the middle lobes and with cavitation 
in the left upper lobe. Case of paracoccidioidomycosis 
concomitant with tuberculosis (acid-fast bacilli positive).
Figure 3 - Chest X-ray showing bilateral lung 
opacities predominantly in the upper lobes. Case of 
paracoccidioidomycosis previously treated for tuberculosis 
with no improvement (acid-fast bacilli negative).
Figure 4 - High-resolution computed tomography scan 
of the chest showing various bilateral cavitary lesions. 
Case of acid-fast bacilli-negative paracoccidioidomycosis.
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Discussion
In the state of São Paulo, PCM and TB are 
common diseases. The incidence of TB is 45 cases per 
100,000 inhabitants. However, neither the incidence 
nor the prevalence of PCM have been well-defined, 
since it is a disease for which reporting is not 
compulsory. Nevertheless, the prevalence of PCM is 
estimated to be 1 to 3 cases per 100,000 inhabitants 
in endemic areas.(6-8) 
In patients presenting a drop in cellular immu-
nity, PCM and TB both occur in a more severe form, 
and such patients can present the two diseases 
concomitantly. Deficient production of certain 
cytokines, such as IFN-γ, IL-12, and IL-23, as well as 
of their receptors, predisposes patients to TB and to 
PCM.(5) The pattern of cytokine production by CD4+ T 
lymphocytes can determine the severity of the clin-
ical profile of these two diseases. The predominance 
of IFN-γ (produced by CD4+ T lymphocytes known as 
T helper 1 cells) is generally associated with a more 
favorable clinical evolution, whereas the predomi-
nance of IL-4, IL-5, and IL-10 (produced by CD4+ T 
lymphocytes designated T helper 2 cells) results in a 
more severe disease progression.(9,10) 
The majority of individuals with PCM are male 
(15:1) and are farm laborers or former farm laborers 
between 30 and 50 years of age. Although such indi-
viduals are often oligosymptomatic, with few physical 
examination findings, they can present pronounced 
alterations on simple chest X-rays and on high-reso-
lution computed tomography scans of the chest.(11-15) 
Pulmonary alterations are typically bilateral, 
predominantly in the middle lobes and spinal cord 
regions.(16,17) 
In contrast, TB affects males and females of all 
ages, the majority of whom are symptomatic and 
present abnormal physical examination findings, as 
well as radiological alterations, which can also be 
bilateral but are typically most pronounced in the 
superior and posterior segments.
Despite these differences, it is not uncommon for 
the differential diagnosis between the two diseases 
to be difficult. There have been various reports of 
the PCM/TB combination. In a study of 338 cases 
of PCM,(12) 46 (13.65%) of the patients were found 
to have also been diagnosed with TB. The patients 
were divided into 3 groups: a) 19 cases, 10 of which 
were inactive (latent TB), and 9 of which were active 
(symptomatic TB at the time of the PCM diagnosis); 
Figure 5 - Sequential imaging of a given patient: a) 
1997. Opacity in the left lung base: negativity for acid-
fast bacilli and positivity for Paracoccidioides brasiliensis; 
b) 2004. Cavitary lesion in the left upper lobe: positivity 
for acid-fast bacilli; good response to anti-tuberculosis 
treatment; and c) Diffuse micronodular opacities (miliary 
pattern). Negativity for acid-fast bacilli and positivity for 
P. brasiliensis with clinical and radiological improvement 
after treatment with trimethoprim-sulfamethoxazole.
a
b
c
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b) 17 cases of patients with PCM who later devel-
oped TB; and c) 10 cases in which the two diagnoses 
were made simultaneously.
In another study,(1) 422 cases of PCM were 
studied. Of those, 23 (5.5%) were also diagnosed 
with TB. Another group of authors studied 147 
patients with PCM and determined that 28 (19%) 
had concomitant TB.(2)
In a study involving 159 patients with PCM,(16) 
24 patients (15.09%) were found to have concomi-
tant TB. 
These results, however, do not differentiate 
between the cases in which there was bacteriolog-
ical confirmation of TB and those with a history of 
previous treatment for TB without bacteriological 
confirmation. 
Another study showed that, of 43 patients with 
PCM, 8 (18.6%) had a history of previous treat-
ment for TB, but only 3 (6.99%) presented positive 
sputum smear microscopy results.(18) Even within 
the indigenous population in Brazil, 2 cases that 
were treated as TB were reported to have later been 
definitively diagnosed as PCM.(19) 
In the present study, we found that, of the 
227 cases evaluated, 36 (15.8%) had been previ-
ously treated for TB, but only 18 (7.9%) had had 
bacteriological and laboratory test confirmation had 
been obtained in only 18 (7.9%). Those 18 patients 
benefited from the specific anti-TB medication, 
being referred to our facility, some years later, with 
clinical complaints and radiological alterations that 
culminated in the diagnosis of PCM. The remaining 
18 patients sought treatment at our facility because 
the treatment they had received provided no clinical 
improvement.
It should be borne in mind that, although the 
combination of PCM and TB has been documented 
in the literature, misdiagnosis is common due to the 
superimposition of and the similarity between their 
clinical and radiological presentations. In addition, 
most of the patients initially sought treatment at 
basic health clinics, where health care workers have 
more experience in dealing with TB, due to its high 
incidence, and are less likely to make a diagnosis 
of PCM. This has rarely happened at tertiary-
care teaching hospitals, where these diseases are 
commonly encountered and diagnoses are typically 
confirmed prior to the initiation of treatment.
The PCM/TB combination is uncommon, and 
it can be difficult to make the differential diag-
nosis on the basis of clinical and radiological data. 
Incorrect treatment increases the chances of pulmo-
nary sequelae, such as fibrosis, bronchiectasis, and 
chronic respiratory failure. Therefore, it is necessary 
to carry out exhaustive bacteriological investigation 
prior to instituting a specific therapeutic regimen 
for TB, as well as to increase the accuracy of and the 
emphasis on testing for fungi in sputum, especially 
at basic health clinics.
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